SOPHiA GENETICS (SOPH) News Today $4.07 -0.17 (-4.01%) Closing price 02/21/2025 03:57 PM EasternExtended Trading$3.75 -0.32 (-7.96%) As of 02/21/2025 07:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period SOPHiA GENETICS to Announce Financial Results for Fourth Quarter and Full Year 2024 on March 4, 2025February 18, 2025 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Sees Large Drop in Short InterestSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a large drop in short interest in the month of January. As of January 31st, there was short interest totalling 19,800 shares, a drop of 34.0% from the January 15th total of 30,000 shares. Approximately 0.0% of the company's shares are short sold. Based on an average daily volume of 53,500 shares, the short-interest ratio is currently 0.4 days.February 15, 2025 | marketbeat.comOne-year-old's rare disorder which leaves her always 'starving'February 15, 2025 | uk.news.yahoo.comWhat a $2 Million Per Dose Gene Therapy Reveals About Drug PricingFebruary 13, 2025 | msn.comSOPHiA GENETICS (NASDAQ:SOPH) Shares Down 4.4% - Here's WhySOPHiA GENETICS (NASDAQ:SOPH) Trading Down 4.4% - Here's WhyFebruary 12, 2025 | marketbeat.comRBC Capital Sticks to Their Buy Rating for SOPHiA GENETICS (SOPH)February 6, 2025 | markets.businessinsider.comSOPHiA GENETICS Launches Comprehensive MRD Tracking CapabilitiesJanuary 28, 2025 | prnewswire.comHealthcare Analytics Industry to Hit USD 133.1 billion by 2029 with 24.3% CAGR | MarketsandMarkets™January 21, 2025 | finance.yahoo.comCancer Biopsy Market Size is Expected to Reach USD 60.92 Billion by 2033, Growing at a CAGR of 7.81%: Straits ResearchJanuary 20, 2025 | finance.yahoo.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Decreases By 15.1%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large decrease in short interest in the month of December. As of December 31st, there was short interest totalling 31,400 shares, a decrease of 15.1% from the December 15th total of 37,000 shares. Based on an average daily trading volume, of 25,600 shares, the short-interest ratio is presently 1.2 days. Currently, 0.1% of the shares of the stock are short sold.January 16, 2025 | marketbeat.comMorgan Stanley Reaffirms Their Hold Rating on SOPHiA GENETICS (SOPH)January 14, 2025 | markets.businessinsider.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Grows By 38.6%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a significant growth in short interest during the month of December. As of December 15th, there was short interest totalling 37,000 shares, a growth of 38.6% from the November 30th total of 26,700 shares. Based on an average daily volume of 24,300 shares, the days-to-cover ratio is currently 1.5 days. Currently, 0.1% of the company's stock are short sold.December 29, 2024 | marketbeat.comCraig-Hallum Initiates Coverage of SOPHiA GENETICS (SOPH) with Buy RecommendationDecember 19, 2024 | msn.comCraig-Hallum bullish on Sophia Genetics, initiates with a BuyDecember 18, 2024 | markets.businessinsider.comCraig Hallum Initiates Coverage on SOPHiA GENETICS (NASDAQ:SOPH)Craig Hallum started coverage on shares of SOPHiA GENETICS in a research note on Wednesday. They set a "buy" rating and a $11.00 price objective on the stock.December 18, 2024 | marketbeat.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Drops By 52.7%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a large decline in short interest during the month of November. As of November 30th, there was short interest totalling 26,700 shares, a decline of 52.7% from the November 15th total of 56,500 shares. Based on an average trading volume of 26,800 shares, the short-interest ratio is presently 1.0 days. Approximately 0.1% of the shares of the stock are sold short.December 12, 2024 | marketbeat.comSOPHiA GENETICS (SOPH) Receives a Buy from RBC CapitalDecember 11, 2024 | markets.businessinsider.comSOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA DDM™ at AMP 2024November 21, 2024 | prnewswire.comMorgan Stanley Sticks to Its Hold Rating for SOPHiA GENETICS (SOPH)November 19, 2024 | markets.businessinsider.comEarnings Release: Here's Why Analysts Cut Their SOPHiA GENETICS SA (NASDAQ:SOPH) Price Target To US$6.00November 8, 2024 | finance.yahoo.comSophia Genetics (NASDAQ:SOPH) Stock Quotes, Forecast and News SummaryNovember 6, 2024 | benzinga.comQ3 2024 Sophia Genetics SA Earnings CallNovember 6, 2024 | uk.finance.yahoo.comSOPHiA GENETICS Third Quarter 2024 Earnings: Misses ExpectationsNovember 6, 2024 | finance.yahoo.comSOPHiA GENETICS Q3 2024 Financial HighlightsNovember 6, 2024 | markets.businessinsider.comSOPHiA GENETICS: Strong Buy Rating Amidst Promising Growth Prospects and Financial StabilityNovember 6, 2024 | markets.businessinsider.comSOPHiA GENETICS Faces Financial Challenges Amid LossesNovember 6, 2024 | finance.yahoo.comSOPHiA GENETICS SA (SOPH) Q3 2024 Earnings Call TranscriptNovember 5, 2024 | seekingalpha.comSOPHiA GENETICS Names New President, Chief Financial OfficerNovember 5, 2024 | marketwatch.comSOPHiA GENETICS SA (SOPH): A Bull Case TheoryNovember 5, 2024 | msn.comSOPHiA GENETICS Promotes Ross Muken to President and Appoints George Cardoza as Chief Financial OfficerNovember 5, 2024 | prnewswire.comSOPHiA GENETICS Reports Third Quarter 2024 ResultsNovember 5, 2024 | prnewswire.comSOPHiA GENETICS (SOPH) to Release Quarterly Earnings on TuesdaySOPHiA GENETICS (NASDAQ:SOPH) will be releasing earnings before the market opens on Tuesday, November 5, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=638077)October 29, 2024 | marketbeat.comRBC Capital Keeps Their Buy Rating on SOPHiA GENETICS (SOPH)October 25, 2024 | markets.businessinsider.comSOPHiA GENETICS to Announce Financial Results for Third Quarter 2024 on November 5, 2024October 22, 2024 | prnewswire.comShort Interest in SOPHiA GENETICS SA (NASDAQ:SOPH) Declines By 22.8%SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the target of a large decline in short interest in the month of September. As of September 30th, there was short interest totalling 14,600 shares, a decline of 22.8% from the September 15th total of 18,900 shares. Based on an average daily volume of 54,500 shares, the days-to-cover ratio is currently 0.3 days. Currently, 0.0% of the company's shares are sold short.October 15, 2024 | marketbeat.comSOPHiA GENETICS SA (NASDAQ:SOPH) Shares Sold by Millennium Management LLCMillennium Management LLC decreased its stake in SOPHiA GENETICS SA (NASDAQ:SOPH - Free Report) by 63.6% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 662,656 shares of the company's stock after selling 1,1October 15, 2024 | marketbeat.comSOPHiA GENETICS SA (NASDAQ:SOPH) Short Interest UpdateSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) saw a large growth in short interest during the month of August. As of August 31st, there was short interest totalling 39,400 shares, a growth of 47.0% from the August 15th total of 26,800 shares. Based on an average daily volume of 75,700 shares, the days-to-cover ratio is currently 0.5 days. Approximately 0.1% of the company's shares are sold short.September 14, 2024 | marketbeat.comSOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024September 14, 2024 | prnewswire.comSOPHiA GENETICS Announces Poster Presentations at ESMO 2024September 12, 2024 | prnewswire.comSOPHiA GENETICS (SOPH) Gets a Buy from TD CowenSeptember 12, 2024 | markets.businessinsider.comSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024September 12, 2024 | prnewswire.comSophia Genetics and AstraZeneca collaborate to expand liquid biopsy test rolloutSeptember 11, 2024 | finance.yahoo.comSOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy TestingSeptember 10, 2024 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Shares Bought by Principal Financial Group Inc.Principal Financial Group Inc. raised its stake in SOPHiA GENETICS SA (NASDAQ:SOPH - Free Report) by 35.9% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,368,378 shares of the company's stock after puSeptember 10, 2024 | marketbeat.comSOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024September 5, 2024 | prnewswire.comSOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM Platform at Morgan Stanley Healthcare Conference 2024September 4, 2024 | prnewswire.comSOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth ConferenceAugust 28, 2024 | prnewswire.comSOPHiA GENETICS SA (NASDAQ:SOPH) Sees Significant Decline in Short InterestSOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) was the recipient of a large decrease in short interest in August. As of August 15th, there was short interest totalling 26,800 shares, a decrease of 61.6% from the July 31st total of 69,800 shares. Based on an average daily trading volume, of 107,300 shares, the days-to-cover ratio is currently 0.2 days. Approximately 0.1% of the shares of the company are sold short.August 28, 2024 | marketbeat.comBodies of Autonomy founder Mike Lynch and his daughter recovered from sunken Bayesian yachtAugust 25, 2024 | techcrunch.comSophia Genetics SA SOPHAugust 22, 2024 | morningstar.com Get SOPHiA GENETICS News Delivered to You Automatically Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter. Email Address SOPH Media Mentions By Week SOPH Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. SOPH News Sentiment▼0.330.60▲Average Medical News Sentiment SOPH News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. SOPH Articles This Week▼32▲SOPH Articles Average Week Get SOPHiA GENETICS News Delivered to You Automatically Sign up to receive the latest news and ratings for SOPH and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PAHC News ZYME News ABCL News REPL News COLL News RCKT News EOLS News PHVS News AVBP News COGT News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:SOPH) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SOPHiA GENETICS SA Please log in to your account or sign up in order to add this asset to your watchlist. Share SOPHiA GENETICS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
